GenEndeavor attending the BIO CEO & Investor Conference, NY 2/26 & 2/27
We are thrilled to announce @GenEndeavor’s participation in the upcoming BIO CEO & Investor Conference, in New York City, NY, on February 26-27, 2024.
At the event, GenEndeavor will showcase our Non-Enzymatic Amplification Technologies (NEAT) platform to usher in a new generation of technologies for molecular diagnostics.
Call for applications: Senior Research Associate
Join our team!
GenEndeavor is seeking individuals with strong expertise in nucleic acid testing technologies (NAT), assay development, and point-of-care diagnostics.
Successful applicants should have at least 2 years of demonstrated experience and knowledge in chemical modification of nucleic acids, lateral flow assay development, chemical ligation of oligonucleotides, and molecular biology techniques in an industry setting.